SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:su-113711"
 

Search: onr:"swepub:oai:DiVA.org:su-113711" > ROCK1 is a potentia...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Smit, Marjon A. (author)

ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • 2014-12-23
  • EMBO,2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:su-113711
  • https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-113711URI
  • https://doi.org/10.15252/msb.20145450DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • AuthorCount:10;
  • Treatment of BRAF mutant melanomas with specific BRAF inhibitors leads to tumor remission. However, most patients eventually relapse due to drug resistance. Therefore, we designed an integrated strategy using (phospho)proteomic and functional genomic platforms to identify drug targets whose inhibition sensitizes melanoma cells to BRAF inhibition. We found many proteins to be induced upon PLX4720 (BRAF inhibitor) treatment that are known to be involved in BRAF inhibitor resistance, including FOXD3 and ErbB3. Several proteins were down-regulated, including Rnd3, a negative regulator of ROCK1 kinase. For our genomic approach, we performed two parallel shRNA screens using a kinome library to identify genes whose inhibition sensitizes to BRAF or ERK inhibitor treatment. By integrating our functional genomic and (phospho)proteomic data, we identified ROCK1 as a potential drug target for BRAF mutant melanoma. ROCK1 silencing increased melanoma cell elimination when combined with BRAF or ERK inhibitor treatment. Translating this to a preclinical setting, a ROCK inhibitor showed augmented melanoma cell death upon BRAF or ERK inhibition in vitro. These data merit exploration of ROCK1 as a target in combination with current BRAF mutant melanoma therapies.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Maddalo, GianlucaStockholms universitet,Institutionen för biokemi och biofysik,University of Utrecht, Netherlands; Netherlands Proteomics Centre, Netherlands(Swepub:su)gmadd (author)
  • Greig, Kylie (author)
  • Raaijmakers, Linsey M. (author)
  • Possik, Patricia A. (author)
  • van Breukelen, Bas (author)
  • Cappadona, Salvatore (author)
  • Heck, Albert J. R. (author)
  • Altelaar, A. F. Maarten (author)
  • Peeper, Daniel S. (author)
  • Stockholms universitetInstitutionen för biokemi och biofysik (creator_code:org_t)

Related titles

  • In:Molecular Systems Biology: EMBO10:121744-42921744-4292

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view